Click Here to Get Updated Version of This Report
Global AI-Enabled Drug Discovery and Clinical Trails Market Analysis, 2020 market research report depicts a deep-dive market analysis of statistics of Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
According to MarkNtel Advisors’ research report titled “Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Analysis, 2020”, the Global AI-Enabled Drug Discovery and Clinical Trials market is anticipated to grow at a CAGR of around 24.5% during 2020-25. AI-enabled drug discovery and clinical trials are witnessing considerable investments in emerging economies such as India, Brazil, and China.
Sudden outbreak of COVID-19 is further setting the stage for massive investments toward quick development and trials of drugs. Therefore, the investments in AI-enabled drug discovery and clinical trials are set to proliferate in North America and Europe. However, the lack of proper regulations reinstructs the growth of AI-Enabled Drug Discovery and Clinical Trials market.
Improving Healthcare Infrastructure in Asia-Pacific Shows Immense Opportunities
The rate of penetration of innovative technologies in healthcare is very high in North America; therefore, the region held the largest market share in 2019. Massive fatalities due to COVID-19 is expected to push the manufacturers and governments toward integrating artificial intelligence solutions to shorten the overall drug discovery and trial life cycle. Therefore, the US is expected to exhibit considerable growth in the deployment of such solutions
The Asia-Pacific region, especially countries such as China, India, and Japan, has an immense scope of adoption of AI-enabled technologies driven by rising healthcare investments and prevailing ecosystems of drug manufacturing. Thus, the region is a key opportunity area for the drug discovery and clinical trial stakeholders through 2025.
Biopharmaceutical Industry Segment Dominated the Market with the Largest Market Share
The biopharmaceutical industry is the main end-user of drug discovery and clinical trials. The sector acquired the highest revenue share in 2019. Moreover, there has been an ongoing demand from the contract research organizations (CROs) and academic research centers for maintaining the workflow of the facilities and rearranging the work for enhancing the quality of work. AI-enabled solutions in the CROs and academic research organizations are growing at an exponential rate catalyzing the overall demand for drug discovery and clinical trials. For improving the drug discovery and clinical trials, the end-users such as biopharmaceutical companies, contract research organizations, and academic institutions are assimilating AI-enabled solutions as stated in the MarkNtel Advisors market research report viz. “Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Analysis, 2020”.
According to MarkNtel Advisors, Accutar Biotechnology, Ardigen, Atomwise Inc., AiCure, LLC, Berg LLC, Cloud Pharmaceuticals, Biovista, Cyclica Inc., Symphony Innovations, GNS Healthcare are few of the leading players in "Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Analysis, 2020”.
Key Questions Answered in the Market Research Report
Market Outlook, Segmentation and Statistics
Frequently Asked Questions
Q. What is the historical year, base year and forecast year considered in the research report on Global AI Enabled Drug Discovery and Clinical Trials Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.
Q. What would be the growth rate or CAGR of the Global AI Enabled Drug Discovery and Clinical Trials Market during 2020-25?
A. The growth rate of the Global AI Enabled Drug Discovery and Clinical Trials Market during 2020-25 is forecast to be around 24.5%.
Q. Who are the key competitors or players operating in the Global AI Enabled Drug Discovery and Clinical Trials Market?
A. Accutar Biotechnology, Ardigen, Atomwise Inc., AiCure, LLC, Berg LLC, Cloud Pharmaceuticals, Biovista, Cyclica Inc., Symphony Innovations, GNS Healthcare are few of the leading players in the Global AI Enabled Drug Discovery and Clinical Trials Market.
Q. Which end-user segment would emerge as an opportunity area for players in Global AI Enabled Drug Discovery and Clinical Trials Market?
A. The biopharmaceutical segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which region would emerge as an opportunity area for players in Global AI Enabled Drug Discovery and Clinical Trials Market?
A. North America region grabbed a significant market share continues to grow at the highest CAGR, presenting immense opportunities for manufacturers and suppliers of the Global AI Enabled Drug Discovery and Clinical Trials Market.
